Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gut and Azithromycin Mechanisms in Infants and Neonates
NCT03676751Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Oct 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin in child mortality (U5MR), sponsored by University of California, San Francisco. Started Oct 2019; status: completed.
02
Drugs
azithromycin
03
Conditions
child mortality (U5MR)
Beyond the preview
Go deeper on NCT03676751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03676751.